Quercetin provides greater cardioprotective effect than its glycoside derivative rutin on isoproterenol-induced cardiac fibrosis in the rat

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 11, 2013, Pages 951-959

  Li, Min ^a   Jiang, Yichuan ^a   Jing, Wuhui ^a   Sun, Bo ^a   Miao, Chunsheng ^a   Ren, Liqun ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Cardiac fibrosis; CTGF; ECM; Quercetin; Rutin; TGF 1

Indexed keywords

ANGIOTENSIN II; CONNECTIVE TISSUE GROWTH FACTOR; GLYCOSIDE; ISOPRENALINE; QUERCETIN; RUTOSIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART; HEART MUSCLE FIBROSIS; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; ENDOMYOCARDIAL FIBROSIS; EXTRACELLULAR MATRIX; GLYCOSIDES; HEART FUNCTION TESTS; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; ISOPROTERENOL; MALE; MYOCARDIUM; ORGAN SIZE; QUERCETIN; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; RUTIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885455893     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0432     Document Type: Article

References (37)

1. Albayrak, F., Bayir, Y., Halici, Z., Kabalar, E., Bayram, E., Ozturk, C., et al. 2009. Preventive effect of amiodarone during acute period in isoproterenolinduced myocardial injury in Wistar rats. Cardiovasc. Toxicol. 9(4): 161-168. doi:10.1007/s12012-009-9049-z. PMID:19714493.
2. Anversa, P., Leri, A., Li, B., Liu, Y., Di Somma, S., and Kajstura, J. 2000. Ischemic cardiomyopathy and the cellular renin-angiotensin system. J. Heart Lung Transplant. 19(8 Suppl.): S1-S11. doi:10.1016/S1053-2498(99)00111-4. PMID: 11016481.
3. Boots, A.W., Haenen, G.R., and Bast, A. 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585(2-3): 325-337. doi:10.1016/j.ejphar.2008.03.008. PMID:18417116.
4. Booz, G.W., and Baker, K.M. 1995. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc. Res. 30(4): 537-543. doi:10.1016/S0008-6363(96)88507-5. PMID:8575002.
5. Brilla, C.G., Zhou, G., Matsubara, L., and Weber, K.T. 1994. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J. Mol. Cell. Cardiol. 26(7): 809-820. doi:10.1006/jmcc.1994.1098. PMID:7966349.
6. Buttke, T.M., and Sandstrom, P.A. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today, 15(1): 7. doi:10.1016/0167-5699(94)90018-3. PMID: 8136014.
7. Chai, W., Garrelds, I.M., de Vries, R., and Danser, A.H. 2006a. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone? Hypertension, 47(4): 665-670. doi:10.1161/01.HYP. 0000205831.39339.a5. PMID:16490840.
8. Chai, W., Hoedemaekers, Y., van Schaik, R.H., van Fessem, M., Garrelds, I.M., Saris, J.J., et al. 2006b. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. J. Renin Angiotensin Aldosterone Syst. 7(4): 225-230. doi: 10.3317/jraas.2006.042. PMID:17318792.
9. Chen, M.M., Lam, A., Abraham, J.A., Schreiner, G.F., and Joly, A.H. 2000. CTGF Expression is Induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 32(10): 1805-1819. doi:10. 1006/jmcc.2000.1215. PMID:11013125.
10. 2-induced apoptosis via antioxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem. Pharmacol. 69(12): 1839. doi:10.1016/j.bcp.2005.03.017. PMID: 15876423.
11. Clarkson, M.R., Gupta, S., Murphy, M., Martin, F., Godson, C., and Brady, H.R. 1999. Connective tissue growth factor: a potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease. Curr. Opin. Nephrol. Hypertens. 8(5): 543-548. doi:10.1097/00041552-199909000-00002. PMID:10541215.
12. Crespy, V., Morand, C., Besson, C., Manach, C., Demigne, C., and Remesy, C. 2002. Quercetin, but not its glycosides, is absorbed from the rat stomach. J. Agr. Food Chem. 50(3): 618-621. doi:10.1021/jf010919h. PMID:11804539.
13. Danser, A.H. 2003. Local renin-angiotensin systems: the unanswered questions. Int. J. Biochem. Cell Biol. 35(6): 759-768. doi:10.1016/S1357-2725(02)00178-4. PMID:12676161.
14. Gao, H., Sun, B., and Miao, C. 2009. Establishment of rat model of large dose isoproternol-induced myocardial ischemic necrosis [J]. Chinese Journal of Biologicals, 3: 028.
15. Geronikaki, A., Gavalas, A., Dislian, V., and Giannoglou, G. 2007. Inhibition of renin-angiotensin system and advanced glycation end products formation: a promising therapeutic approach targeting on cardiovascular diseases. Cardiovasc. Hematol. Agents Med. Chem. 5(4): 249-264. doi:10.2174/187152507782109926. PMID:17979687.
16. Grotendorst, G.R. 1997. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev. 8(3): 171. doi:10.1016/S1359-6101(97)00010-5. PMID:9462483.
17. Hollman, P., and Katan, M. 1999. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37(9-10): 937. doi:10.1016/S0278-6915 (99)00079-4. PMID:10541448.
18. Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R.T., Yu, L., et al. 2006. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 69(1): 105-113. doi:10.1038/sj.ki.5000011. PMID: 16374430.
19. Ito, Y., Aten, J., Bende, R.J., Oemar, B.S., Rabelink, T.J., Weening, J.J., et al. 1998. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 53(4): 853-861. doi:10.1111/j.1523-1755.1998.00820.x. PMID:9551391.
20. Janero, D.R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9(6): 515-540. doi:10.1016/0891-5849(90)90131-2. PMID:2079232.
21. Kleemann, R., Verschuren, L., Morrison, M., Zadelaar, S., van Erk, M.J., Wielinga, P.Y., et al. 2011. Anti-inflammatory, anti-proliferative and antiatherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis, 218(1): 44-52. doi:10.1016/j.atherosclerosis.2011.04.023. PMID:21601209.
22. Liu, R.M., and Gaston Pravia, K. 2010. Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic. Biol. Med. 48(1): 1-15. doi:10.1016/j. freeradbiomed.2009.09.026. PMID:19800967.
23. Morand, C., Manach, C., Crespy, V., and Remesy, C. 2000. Quercetin 3-O-betaglucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic. Res. 33(5): 667-676. doi:10.1080/10715760000301181. PMID:11200097.
24. Moskaug, J.O., Carlsen, H., Myhrstad, M., and Blomhoff, R. 2004. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev. 125(4): 315-324. doi:10.1016/j.mad.2004.01.007. PMID:15063108.
25. Nguyen, G., Delarue, F., Burckle, C., Bouzhir, L., Giller, T., and Sraer, J.D. 2002. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109(11): 1417-1427. doi:10.1172/JCI200214276. PMID:12045255.
26. Nirmala, C., and Puvanakrishnan, R. 1996. Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 159(2): 85-93. doi:10.1007/BF00420910. PMID:8858558.
27. Paradis, V., Dargere, D., Vidaud, M., de Gouville, A.C., Huet, S., Martinez, V., et al. 2003. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology, 30(4): 968-976. doi:10.1002/hep.510300425. PMID:10498649.
28. Pawlikowska-Pawlega, B., Gruszecki, W.I., Misiak, L.E., and Gawron, A. 2003. The study of the quercetin action on human erythrocyte membranes. Biochem. Pharmacol. 66(4): 605-612. doi:10.1016/S0006-2952(03)00344-7. PMID:12906925.
29. Porter, K.E., and Turner, N.A. 2009. Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol. Ther. 123(2): 255-278. doi:10.1016/j.pharmthera. 2009.05.002. PMID:19460403.
30. Rona, G., Chappel, C.I., Balazs, T., and Gaudry, R. 1959. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch. Pathol. 67(4): 443-455. PMID:13636626.
31. Sawyer, D.B., Siwik, D.A., Xiao, L., Pimentel, D.R., Singh, K., and Colucci, W.S. 2002. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 34(4): 379-388. doi:10.1006/jmcc.2002.1526. PMID:11991728.
32. Singal, P.K., Kapur, N., Dhillon, K.S., Beamish, R.E., and Dhalla, N.S. 1982. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60(11): 1390-1397. doi:10.1139/y82-207. PMID:7151008.
33. Siwik, D.A., Pagano, P.J., and Colucci, W.S. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280(1): C53-C60. PMID:11121376.
34. Weber, K.T., and Brilla, C.G. 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation, 83(6): 1849-1865. doi:10.1161/01.CIR.83.6.1849. PMID:1828192.
35. Yamamoto, N., Moon, J.H., Tsushida, T., Nagao, A., and Terao, J. 1999. Inhibitory effect of quercetin metabolites and their related derivatives on copper ioninduced lipid peroxidation in human low-density lipoprotein. Arch. Biochem. Biophys. 372(2): 347-354. doi:10.1006/abbi.1999.1516. PMID:10600174.
36. Yang, C.Y., Hsiu, S.L., Wen, K.C., Lin, S.P., Tsai, S.Y., Hou, Y.C., et al. 2005. Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J. Food Drug Anal. 13(3): 244-250.
37. Zhou, R., Xu, Q., Zheng, P., Yan, L., Zheng, J., and Dai, G. 2008. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur. J. Pharmacol. 586(1): 244-250. doi:10.1016/j.ejphar.2008.02.057. PMID: 18384769.